Guichang Li
State Key Laboratory Of Respiratory Disease & National Clinical Research Center For Respiratory Disease
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Immune imprinting toward SARS-CoV-2 XBB: implications for vaccine strategy and variant risk assessment.
Journal: Signal transduction and targeted therapy
Published: May 22, 2025
Progress on Respiratory Syncytial Virus Vaccine Development and Evaluation Methods.
Journal: Vaccines
Published: January 19, 2025
Effect of wild-type vaccine doses on BA.5 hybrid immunity, disease severity, and XBB reinfection risk.
Journal: Journal of virology
Published: November 05, 2024
Immune escape of BA.2.86 is comparable to XBB subvariants from the plasma of BA.5- and BA.5-XBB-convalescent subpopulations.
Journal: Journal of medical virology
Published: October 12, 2023
SARS-CoV-2 vaccination-infection pattern imprints and diversifies T cell differentiation and neutralizing response against Omicron subvariants.
Journal: Cell discovery
Published: July 29, 2022
Development of SARS-CoV-2 animal vaccines using a stable and efficient NDV expression system.
Journal: Journal of medical virology
Published: July 17, 2022
Heterologous boosting with third dose of coronavirus disease recombinant subunit vaccine increases neutralizing antibodies and T cell immunity against different severe acute respiratory syndrome coronavirus 2 variants.
Journal: Emerging microbes & infections
Published: March 01, 2022
SARS-CoV-2-specific CD4+ T cells are associated with long-term persistence of neutralizing antibodies.
Journal: Signal transduction and targeted therapy
Published: January 07, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026